Symphonic Capital

What Symphonic Capital does

Symphonic Capital is an early-stage venture capital firm founded in 2022 by Sydney Thomas and based in Oakland, California. The firm invests at the pre-seed and seed stages, writing checks of $1-3M into companies valued at $10M or less that have a minimum viable product and first customer secured. Its stated investment thesis targets AI-enabled companies building essential systems across health, wealth, and climate resilience, with the active portfolio concentrated in HealthTech and FinTech and spanning 19-23 companies including Flourish Care, RevelAI, Rosarium Health, Lōvu Health, Canopie, Aura Finance, Remynt, Giving Credit, and Honeycomb Credit.

The firm's go-to-market is a sales-led, relationship-driven sourcing model executed through its proprietary AI-native CRM, "Symphonic DealFlow," which tracks 1,364+ deals, LP relationships, and portfolio company KPIs. Distribution relies on direct network engagement, a dealflow application portal, founder referrals, thought-leadership content (newsletter, blog), and earned media (TechCrunch, Forbes). Symphonic emphasizes operator-led value-add, drawing on the founding team's prior operating experience — Sydney Thomas previously helped scale a Silicon Valley fund from solo GP to a $200M+ platform with 400+ portfolio companies, and Co-General Partner Shruti Shah previously co-founded Move Loot (YC-backed, $22M raised) and served as EIR at Nike and Silicon Valley Bank.

Symphonic's revenue model is traditional venture fund management: it raised $13.5M in LP commitments for its inaugural Fund I in 2023 and generates economics through management fees and carried interest on portfolio equity ownership. The firm is backed by institutional LPs (Bank of America, Known, Candide, Illumen Capital, Sweater Ventures) and individual operators (Michael Siebel/YC, Wayee Chu/REACH Capital, Laura Spiekerman/Alloy, David Whelan/Town Hall Ventures). The customer base comprises two segments — early-stage founders (pre-seed to seed) receiving capital plus operational guidance, and LPs receiving fund returns and impact exposure — with no per-product pricing or recurring commercial contracts.

Name

Symphonic Capital

Legal name

Symphonic Capital

Website

https://symphoniccapital.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Symphonic Capital is an early-stage venture capital firm (Oakland, CA; Fund I: $13.5M) that invests $1-3M pre-seed checks at <$10M valuations into AI-enabled HealthTech, FinTech, and climate resilience startups, operated by founder-led GPs Sydney Thomas and Shruti Shah.

Ownership category

akta.pro rank

Product category

Venture Capital / Pre-Seed Investing

NAICS

Other Investment Pools and Funds (5259), Other Financial Vehicles (525990), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Pre-seed venture capital
• Early-stage investing
• AI-enabled startups
• Fund management
• Impact investing

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. VC Fund Management: Traditional venture capital model generating returns through equity ownership in portfolio companies. Firm management fees and carry on fund returns.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Symphonic Capital is an early-stage venture capital firm that invests $1-3M pre-seed rounds in AI-enabled companies valued under $10M, primarily in HealthTech, FinTech, and climate resilience. The firm partners with founders post-product launch who have secured their first customer, providing capital alongside operational guidance, KPI development, network access, and follow-on capital deployment upon hitting milestones.

Product overview

Symphonic Capital is an early-stage venture capital firm that does not offer commercial products or services. The firm manages a $13.5M Fund I and provides operational guidance and capital to pre-seed founders building AI-enabled companies in health, wealth, and climate resilience. The firm has developed an internal AI-native CRM called 'Symphonic DealFlow' for deal flow management and LP relations, but this is an internal operational tool, not an external product offering.

Differentiator

Problem solved

Functional benefit

Named customers9 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• REACH Capital: Early-stage VC investing in the future of learning and work, with strong focus on diverse founders. LP in Symphonic Capital; comparable emerging manager profile and sector overlap in HealthTech/EdTech.
• SoGal Ventures: Early-stage global venture firm investing in diverse founders. Comparable pre-seed/seed check sizes and diversity-first thesis directly parallel to Symphonic's positioning.
• Ulu Ventures: Early-stage venture firm investing in AI-enabled startups with a focus on HealthTech and FinTech. Co-led RevelAI Health with Symphonic Capital, making it a directly comparable seed-stage AI investor with similar sector focus.
• Camelback Ventures: Pre-seed accelerator and fund supporting BIPOC entrepreneurs. Similar pre-seed stage focus, diversity thesis, and impact-driven mission make it a directly comparable emerging manager.
• Better Ventures: Early-stage fund backing founders solving big problems in climate, health, and economic equity. LP in Symphonic Capital; comparable mission-aligned pre-seed/seed strategy.
• Kapor Capital: Early-stage impact fund focused on closing gaps of access, opportunity, and outcomes for underrepresented communities. Operates similar pre-seed/seed check sizes and diversity-focused thesis as Symphonic.
• Collide Capital: Early-stage fund investing in Black, Latinx, and other underrepresented founders. Participated in Flourish Care's seed round with Symphonic; directly comparable pre-seed/seed fund with diversity thesis.
• Zeal Capital Partners: Early-stage VC focused on underrepresented founders building transformative companies. Led Flourish Care's $5.7M seed alongside Symphonic; directly comparable for diverse-founder pre-seed/seed strategy.

Broad incumbents

• Acumen America: Larger impact-focused early-stage fund targeting companies serving low-income Americans. Sydney Thomas serves on the board; broader stage and larger AUM make it an incumbent peer with overlapping thesis.
• Town Hall Ventures: Healthcare-focused VC investing in companies serving vulnerable populations. LP in Symphonic Capital; broader AUM but overlapping HealthTech thesis targeting underserved communities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/symphonic-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symphonic Capital